Population-based surveillance for invasive pneumococcal disease in homeless adults in Toronto

PLoS ONE

Volumn 4, Issue 9, 2009, Pages

  Plevneshi, Agron ^a,b   Svoboda, Tomislav ^c   Armstrong, Irene ^d   Tyrrell, Gregory ^a,e   Miranda, Anna ^d   Green, Karen ^a,b   Low, Donald ^a,b   McGeer, Allison ^a,b   Chen, D ^f   Davis, I ^g   Kitai, I ^g   Devila, E ^h   Devlin, H R ⁱ   Muller, M ⁱ   Dick, H ^j   Downey, J ^k   Powis, J ^k   Garrod, P ^l   Rau, N ^l   Grossman, R ^m   Sarabia, A ^m   Jamieson, F ⁿ   Kapala, J ^o   Krajden, S ^p   Lee, K S ^q   Baqi, M ^q   Loeb, M ^r   Smaill, F ^r   Lovinsky, R ^s   Rose, D ^s   Braithwaite, J ^s   Lovgren, M ^e   Matlow, A G ^t   Richardson, S ^t   Mederski, B ^u   Katz, K ^u   Moloo, Z ^v   Richardson, D ^v   Quan, C ^v   Naus, M ^w   Ostrowska, K ^x   Shokry, P ^y   Simor, A E ^z   Vearncombe, M ^z   Sturman, D ^aa   Van Nostrand, P ^ab   Walmsley, S ^ac   Gold, W ^ac   Willey, B ^b   Pong Porter, S ^b   Yaffe, B ^d   Yamamura, D ^ad   Silverman, M ^ae   Robertson, R ^af   Volkening, G ^ag   more..

^a Toronto Invasive Bacterial Diseases Network   (Canada)

^b MOUNT SINAI HOSPITAL   (Canada)

^c Centre for Research on Inner City Health   (Canada)

^d CITY OF TORONTO   (Canada)

^e National Centre for Streptococcus   (Canada)

^f York Central Hospital Richmond Hill   (Canada)

^g Rouge Valley Health System   (Canada)

^h Peel Health   (Canada)

ⁱ ST MICHAEL'S HOSPITAL   (Canada)

^j Vita Tech Laboratories   (Canada)

^k TORONTO EAST GENERAL HOSPITAL   (Canada)

^l Halton Healthcare Services   (Canada)

^m CREDIT VALLEY HOSPITAL   (Canada)

ⁿ PUBLIC HEALTH ONTARIO   (Canada)

^o DYNACARE LABORATORIES   (Canada)

^p ST JOSEPH S HEALTH CENTRE   (Canada)

^q HUMBER RIVER REGIONAL HOSPITAL   (Canada)

^r HAMILTON HEALTH SCIENCES   (Canada)

^s SCARBOROUGH HOSPITAL   (Canada)

^t HOSPITAL FOR SICK CHILDREN   (Canada)

^u NORTH YORK GENERAL HOSPITAL   (Canada)

^v William Osler Health Care Centre   (Canada)

^w BRITISH COLUMBIA CENTRE FOR DISEASE CONTROL   (Canada)

^x Trillium Health Centre Missassauga   (Canada)

^y MARKHAM STOUFFVILLE HOSPITAL   (Canada)

^z SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^aa Bridgepoint Health   (Canada)

^ab TORONTO REHABILITATION INSTITUTE   (Canada)

^ac UNIVERSITY HEALTH NETWORK   (Canada)

^ad MDS Laboratories   (Canada)

^ae LAKERIDGE HEALTH CORPORATION   (Canada)

^af Royal Victoria Hospital Barrie   (Canada)

^ag SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ADULT; AGE; AGED; ALCOHOL ABUSE; ARTICLE; BACTERIAL TRANSMISSION; CANADA; CONTROLLED STUDY; DISEASE SURVEILLANCE; EPIDEMIC; FEMALE; HIGH RISK POPULATION; HOMELESSNESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROSPECTIVE STUDY; RISK REDUCTION; SEROTYPE; SMOKING; STREPTOCOCCUS PNEUMONIA; VACCINATION; ADOLESCENT; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PNEUMOCOCCAL INFECTION; STREPTOCOCCUS PNEUMONIAE;

STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; HIV INFECTIONS; HOMELESS PERSONS; HUMANS; MALE; MIDDLE AGED; ONTARIO; PNEUMOCOCCAL INFECTIONS; PROSPECTIVE STUDIES; SMOKING; STREPTOCOCCUS PNEUMONIAE;

EID: 70349667122     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007255     Document Type: Article

References (38)

1. Ortqvist A, Hedlund J, Kalin M. Streptococcus pneumoniae: epidemiology, risk factors, and clinical features. 2005 Semin Respir Crit Care Med 6: 563-574.
2. Greene CM, Kyaw MH, Ray SM, Schaffner W, Lynfield R, et al. (2006) Preventability of invasive pneumococcal disease and assessment of current polysaccharide vaccine recommendations for adults: United States, 2001-2003. Clin Infect Dis 43: 141-150.
3. Burman LA, Norrby R, Trollfors B (1985) Invasive pneumococcal infections: incidence, predisposing factors and prognosis. Rev Infect Dis 7: 133-142.
4. McKenzie H, Reid N, Dijkhuizen RS (2000) Clinical and microbiological epidemiology of Streptococcus pneumoniae bacteremia. J Med Microbiol 49: 361-366.
5. Nuorti JP, Bulter JC, Farley MM, Harrison LH, McGeer A, et al. (2000) Cigarette smoking and invasive pneumococcal disease. NEJM 342: 681-689.
6. Pastor P, Medley F, Murphy TV (1998) Invasive pneumococcal disease in Dallas County, Texas: results from population based surveillance in 1995. Clin Infect Dis 26: 590-595.
7. Shariatzadeh MR, Huang JQ, Tyrrell GJ, Johnson MM, Marrie TJ (2005) Bacteremic pneumococcal pneumonia: a prospective study in Edmonton and neighbouring municipalities. Medicine (Baltimore) 84: 147-161.
8. Mufson MA, Kruss DM, Wasil RE, Metzger WI (1974) Capsular types and outcome of bacteremic pneumococcal disease in the antibiotic era. Arch Int Med 134: 505-510.
9. Mercat A, Nguyen J, Dautzenberg (1991) An outbreak of pneumococcal pneumonia in two men's shelters. Chest 99: 147-151.
10. De Maria A, Browne K, Berk SL, Sherwood EJ, McCabe WR (1980) An outbreak of type 1 pneumococcal pneumonia in a men's shelter. JAMA 244: 1446-1149.
11. Birtles A, McCarthy N, Sheppard CL, Rutter H, Guiver M, et al. (2005) Multilocus sequence typing directly on DNA from clinical samples and a cultured isolate to investigate linked fatal pneumococcal disease in residents of a shelter for homeless men. J Clin Microbiol 43: 2004-2008.
12. Daneman N, McGeer A, Green K, Low DE, Toronto Invasive Bacterial Diseases Network (2006) Macrolide resistance in bacteremic pneumococcal disease: implications for patient management. Clin Infect Dis 43: 432-438.
13. Kumar D, Humar A, Plevneshi A, Green K, Prasad GV, et al. (2007) Invasive pneumococcal disease in solid organ transplant recipients - 10-year prospective population surveillance. Am J Transplant 7: 1209-1214.
14. Kumar D, Humar A, Plevneshi A, Siegal D, Franke N, et al. (2008) Invasive pneumococcal disease in adult hematopoietic stem cell transplant recipients: a decade of prospective population-based surveillance. Bone Marrow Transplant 41: 743-747.
15. City of Toronto Public Health. Homelessness Report card Street Needs Assessment staff report (http://www.toronto.ca/housing/streetneeds.htm) and Housing and Homelessness Report card, 2003. (http://www.toronto.ca/ homelessness/index.htm; accessed June 19, 2008.
16. Al-Sukhni W, Avarino P, McArthur MA, McGeer A (2008) Impact of public vaccination programs on adult vaccination rates: two examples from Ontario, Canada. Vaccine 26: 1432-1437.
17. National Advisory Committee on Immunization. Active Immunizing Agents, Part 4 of Canadian Immunization Guide, 7th edition, 2006. available at http://www.phac-aspc.gc.ca/publicat/cig-gci/p04-pneu-eng.php.
18. Hwang SW (2001) Homelessness and health. CMAJ 164: 229-233.
19. Musher DM, Alexandraki I, Graviss EA, Yanbely E, Eid A, et al. (2000) Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study. Medicine (Baltimore) 79: 210-221.
20. Clinical and Laboratory Standards Institute (2006) Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 7th ed. CLSI document M7-A7. Clinical and Laboratory Standards Institute, Wayne, PA.
21. Turnbull J, Muckle W, Masters C (2007) Homelessness and health. CMAJ 177: 1065-1066.
22. Pritchard JW, Puzey JW (2004) Homelessness-on the health agenda in Wales? Rev Environ Health 19: 363-379.
23. Frankish CJ, Hwang SW, Quantz D (2005) Homelessness and health in Canada: research lessons and priorities. Can J Public Health 96 Suppl 2: S23-S29.
24. Garibaldi B, Conde-Martel A, O'Toole TP (2005) Self-reported comorbidities, perceived needs, and sources for usual care for older and younger homeless adults. J Gen Intern Med 20: 726-730.
25. O'Toole TP, Gibbon JL, Seltzer D, Hanusa BH, Fine MJ (2002) Urban homelessness and poverty during economic prosperity and welfare reform: changes in self-reported comorbidities, insurance, and sources for usual care, 1995-1997. J Urban Health 79: 200-210.
26. Flannery B, Heffernan RT, Harrison LH, Ray SM, Reingold AL, et al. (2006) Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann Int Med 144: 1-9.
27. de Roux A, Cavalcanti M, Marcos MA, Garcia E, Ewig S, et al. (2006) Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia. Chest 129: 1219-1225.
28. Kyaw MH, Rose CE, Fry AM, Singleton JA, Moore Z, et al. (2005) The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis 192: 377-386.
29. Turett GS, Blum S, Telzak EE (2001) Recurrent pneumococcal pneumonia. Arch Intern Med 161: 2141-2144.
30. Rodriguez-Creixems M, Munoz P, Miranda E, Pelaez T, Alonso R, et al. (1996) Recurrent pneumococcal bacteremia. A warning of immunodeficiency. Arch Intern Med 156: 1429-1434.
31. Einarsdottir HM, Erlendsdottir H, Kristinsson KG, Gottfredsson M (2005) Nationwide study of invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect 11: 744-749.
32. King MD, Whitney CG, Parekh F, Farley MM, Active Bacterial Core Surveillance Team/Emerging Infections Program Network (2003) Recurrent invasive pneumococcal disease: a population-based assessment. Clin Infect Dis 37: 1029-1036.
33. McEllistrem MC, Mendelsohn AB, Pass MA, Elliott JA, Whitney CG, et al. (2002) Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 185: 1364-1368.
34. Marra CA, Patrick DM, Marra F (2000) A cost-effectiveness analysis of pneumococcal vaccination in street-involved, HIV-infected patients. Can J Public Health 91: 334-339.
35. O'Brien KL, Hochman M, Goldblatt D (2007) Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue? Lancet Infect Dis 7: 597-606.
36. Targonski PV, Poland GA (2007) Pneumococcal vaccination in adults: Recommendations, trends, and prospects. Cleve Clin J Med 74: 401-414.
37. Sisk JE, Whang W, Butler JC, Sneller VP, Whitney CG (2004) Cost-effectiveness of vaccination against invasive pneumococcal disease among people 50 through 64 years of age: role of comorbid conditions and race. Ann Intern Med 138: 960-968.
38. Christenson B, Hedlund J, Lundbergh P, Ortqvist A (2004) Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. Eur Respir J 23: 363-368.